Your session is about to expire
← Back to Search
RSI MRI Monitoring for Prostate Cancer (ProsRSI Trial)
ProsRSI Trial Summary
This trial will test whether an MRI can predict how well a patient will respond to radiation therapy and androgen deprivation therapy for high-risk, localized prostate cancer.
ProsRSI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowProsRSI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ProsRSI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have another cancer, but it's either in remission or won't affect my prostate cancer treatment.I have had treatments like cryotherapy or surgery for prostate cancer.My prostate cancer is high-risk with a PSA over 20, or it's in an advanced stage, or my Gleason score is 8 or higher.I am scheduled for radiotherapy with hormone therapy before and during treatment.I have had radiation therapy to my pelvic area before.I am a man over 18 with confirmed prostate cancer.I plan to follow standard care for my prostate cancer treatment.I am in good health and can take care of myself.
- Group 1: RSI-MRI
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this trial still open?
"This medical experiment, which was initially uploaded to clinicaltrials.gov on December 29th 2020 and updated as recently as May 16th 2022, is currently recruiting participants."
What is the total population size participating in this investigation?
"Affirmative. According to data hosted on clinicaltrials.gov, this medical experiment is currently enrolling patients. Initially posted in December 2020 and last edited in May 2022, the study seeks 100 participants across a single site."
Is Restriction Spectrum Imaging Magnetic Resonance Imaging a reliable diagnostic tool for patients?
"Our internal assessment of Restriction Spectrum Imaging Magnetic Resonance Imaging's safety resulted in a score of 2, as the technology has not yet been evaluated for efficacy but does possess some evidence regarding its safety."
Share this study with friends
Copy Link
Messenger